Introduction

OTC Pharmaceuticals in Austria - Industry and Country Analysis provides five forces Industry analysis, along with PESTLE country analysis of Austria. This report concludes with profiles of the leading companies in the Austrian OTC pharmaceuticals market.

Scope of this research

• Contains data on market value, volume and/or segmentation for OTC Pharmaceuticals in Austria.
• Incorporates in-depth five forces competitive environment analysis.
• analyzes the political, economic, social, technological, legal and environmental (PESTLE) structure of Austria.
• The leading companies are identified with supporting key financial metrics (where available)

Research and analysis highlights

The Austrian OTC pharmaceuticals market generated total revenues of $825 million in 2009, representing a compound annual growth rate (CAGR) of 2.8% for the period spanning 2005-2009.

Cough and cold preparations sales proved the most lucrative for the Austrian OTC pharmaceuticals market in 2009, generating total revenues of $204.5 million, equivalent to 24.8% of the market's overall value.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.8% for the five-year period 2009-2014, which is expected to drive the market to a value of $947.8 million by the end of 2014.

Key reasons to purchase this research

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials